PTH and chronic kidney disease: Thus, future treatment trials of SHPT in CKD, especially early stage CKD (3a and 3b), should consider high-dose vitamin D supplementation to lower or stabilize PTH levels, but will need to consider race, specifically in BA, when establishing PTH treatment targets.